Skip to main content

Clinical Trial for New Corona Virus Approved for Hydroxychloroquine in US


Hydroxychloroquine clinical trial for new coronary pneumonia approved in the US by the US-FDA

According to a recent report from the US Newsweek website, Novartis Pharmaceuticals, headquartered in Switzerland, said it has reached an agreement with the US Food and Drug Administration to launch a new anti-malarial drug hydroxychloroquine treatment in the United States Clinical trials of hospitalized patients with pneumonia. The entire trial involved 400 patients to assess the effectiveness of the drug.

According to the US Centers for Disease Control and Prevention, there are currently no effective therapies and vaccines that can cure new coronary pneumonia.

In recent weeks, a number of clinical tests have been conducted around the world to determine whether hydroxychloroquine can relieve some symptoms of new coronary pneumonia, but the results obtained are very different.

US President Donald Trump previously said in a White House briefing and Twitter that the drug has potential therapeutic effects, and that the United States has stored 29 million hydroxychloroquine, but this has not been confirmed.

Drugs used in Coronavirus trial

Novartis said that clinical trials will be carried out in "a dozen places" in the United States, and volunteer recruitment will begin in the next few weeks. The drugs used in the trials will be provided by the company's generic and biosimilars departments.

Trials Approved by USFDA Simulation for Hydroxychloroquine in US for COVID-19

It is reported that in this trial, patients will be randomly divided into three groups: the first group taking hydroxychloroquine; the second group taking hydroxychloroquine combined with azithromycin (an antibiotic).

Is hydroxychloroquine beneficial to COVID-19 patients?

The third group taking placebo drugs. John Chua, Chief Medical Officer of Novartis, said:
"It is very important to answer the scientific question of whether hydroxychloroquine is beneficial to patients with new coronary pneumonia. We hope this randomized, placebo-controlled study can solve this problem."

Novartis plans co-sponsor clinical trials

It is reported that in addition to hydroxychloroquine, Novartis also plans to sponsor or co-sponsor clinical trials to study the efficacy of kinase inhibitors lucotinib and canastuzumab in the treatment of inpatients with new coronary pneumonia.



 

Author's Bio

Doctor Shawna Reason, Virologist
Dr. Shawna Reason
Name: Shawna Reason

Education: MBBS, MD

Occupation: Medical Doctor / Virologist 

Specialization: Medical Science, Micro Biology / Virology, Natural Treatment

Experience: 15 Years as a Medical Practitioner

About Me | Linkedin | Quora Profile | Medium Profile | Twitter



Labels:

Comments

Post a Comment

Popular posts from this blog

What is Netting with bubbles-whale hunting?

  "Netting" with bubbles-whale hunting Not all members of the whale family are as agile and good at hunting as killer whales and dolphins. Huge species such as humpback whales will suffer a lot when catching agile fish. As a result, these deep-sea monsters have evolved very sophisticated hunting techniques. The bubble net feeding we are going to introduce today is one of them. All animals in nature have two basic instincts, namely foraging and reproduction. Reproduction is to ensure the continuation of genes, so I won’t go into details today. The fundamental purpose of foraging is to continue its own existence, so as small as an individual animal, as large as an entire population, having an efficient foraging strategy increases the chance of survival.   There are many ways of foraging for animals in nature. Some take the initiative, some wait for rabbits, and some have evolved a very sophisticated way of foraging, which is so sophisticated that it requires acquired le...
Post a Comment
Read more

Banana Bunchy Top Disease

Correct understanding of banana bundle top disease Banana bunchy top disease, also known as banana banana disease, bush top disease, scallion banana or shrimp banana, mainly damages bananas and sometimes plantains. It occurs in Guangxi, Guangdong, Hainan, Fujian and Yunnan. The incidence of banana gardens with severe incidence can reach 10% -30%, or even 50% -80%, but most banana gardens occur sporadically. Plants that are susceptible to disease early are dwarfed and do not bud. Plants that are susceptible only at the current bud stage have fewer fruits and no commercial value. The most prominent symptom of banana bunchy top disease is that the newly grown leaves are shorter and narrower than one, so that the diseased plant is short, the leaves are hard and straight, and they grow together in bundles. The veins, petioles and false stems of the diseased leaves showed thick green streaks of intermittent and varying lengths. Banana farmers call the thick green stripes on the pe...
Post a Comment
Read more